Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis Healthcare CFO...

    Fortis Healthcare CFO Gagandeep Singh Bedi resigns

    Written by Ruby Khatun Khatun Published On 2018-08-31T11:28:27+05:30  |  Updated On 16 Aug 2021 11:29 AM IST

    New Delhi: Fortis Healthcare on Thursday said its Chief Financial Officer Gagandeep Singh Bedi has resigned citing personal reasons.


    The Board of Directors of the company at its meeting held yesterday have considered Bedi's resignation from the services of the company, and accepted the same, with effect from September 30, 2018, Fortis Healthcare said in a filing to BSE.

    The resignation is due to personal reasons, it added.

    Gagandeep Singh Bedi is the first senior company executive to leave the organization post-stake-sale to Malaysia-based IHH Healthcare.


    Medical dialogues had earlier reported that Fortis board had unanimously accepted a binding offer from Malaysia's IHH Healthcare Berhad to invest Rs 4,000 crore in it by way of preferential allotment at Rs 170 per share.


    Read also: IHH Healthcare: Meet the Highest Bidder of Fortis Healthcare


    All in all, IHH Healthcare is expected to shell out a total of Rs 7,300 crore to acquire a 57.1% stake, provided its open offer for 26 percent stake is fully subscribed.


    The senior management of Fortis had come under criticism for lapses in respect of loans granted to entities controlled by former promoters. However, the management had denied the charges.


    Gagandeep Singh Bedi had joined Hospital chain Fortis in 2011 from Philips Healthcare, Netherlands, and had set up the supply chain and shared services function. In 2014, Bedi had appointed Bedi as the firm CFO after its earlier CFO Sandeep Puri had resigned from the post.

    CFOChief Financial OfficerFortisFortis HealthcareGagandeep Singh BediIHHIHH Healthcarepersonal reasonsresignationresigns
    Source : With Agency Inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok